News

Indicates that reimbursement for new slate of Alzheimer’s treatments will occur only with the completion of studies to support full approval.

Using uMotif eCOA/ePRO data capture app, significant ethnic disparities in pain recognition and management are revealed.

Latest number of oncology clinical trials from ClinicalTrials.gov.

Under new agreement, companies can receive biometric data services from Quanticate coupled with global resourcing solutions from KPS Life.

Caregiver-completed pediatric survey was developed in 12 different languages, including new translated versions to ensure comparable measures.

Benchmark survey provides timely insights into clinical trial sites' relationships with sponsors and CROs post-pandemic.

Partnership will enable international sponsors to deliver patient payments globally, including China.

This latest guidance provides a 15-year update on the recommendations, including the use of CGM devices.

Facility upgrade will support clinical supply demand for CGT development.

Agency hopes to update and improve its advisory committee composition and operations—to help FDA scientists “get the best advice possible.”

Harsha K. Rajasimha, PhD, founder and executive chairman, IndoUSrare, provides the OCT audience insights into better achieving DEIA clinical trials.

In this Q&A, Craig Lipset offers additional insights following the announcement that CVS will be closing its clinical trial services business by the end of the year.

Allucent partners with THREAD to launch Allucent Patient Direct Trials, a DCT offering focused on small and mid-sized biotech companies.

New solution delivers simplified questionnaire licensing and localizations, streamlined device logistics, and improved data integrity.

UCB will adopt Veeva ePRO and Veeva eConsent.

New capability added to VIDA Intelligence Platform will streamline quality-controlled data curation.

Latest enhancements will optimize Omnichannel capabilities for ROI reporting.

The latest people and business news from the past month, all in one place.

EMA opens formal consultation on the pros and cons of basing pivotal evidence for new drug submissions on SAT data.

Worldwide will serve as Every Cure’s clinical trial and drug development partner.

Parexel identified five roadblocks to participation and eight solutions for designing more equitable clinical trials for transgender and nonbinary patients.

Tool targets advanced drug monitoring and safety—and enables access to real-world data.

Clinvest Research specializes in chronic diseases and conditions including migraine, arthritis, and diabetes.

New technology aims to streamline cancer treatment process.

Acquisition of two previously merged companies bolsters ACRS’s patient-centric solutions for clinical development.

French and Spanish CROs combine on expertise to address cross-country clinical trials.

Profiles are based on data from more than 60 million patients, with aim to enable adoption of digital twins and improve patient centricity in drug development.

Recommendations apply to where some or all the trial-related activities occur at locations other than traditional clinical trial sites.

Clariness tasked with gathering data on digital device usage behaviors, app and notification preferences, and previous trial experiences.

Flatiron Health’s scalable EHR-to-EDC technology to enable efficient site data transfer for faster access to cleaner data with less burden.